EPO Patents = 1

Forward Citations = 33

Loading Chart...

11 inventors (with patents filed for the assignee):

Yanming Zu (8 out of 8 patents)

Salah Uddin Ahmed (8 out of 25 patents)

Tahseen A Chowdhury (7 out of 16 patents)

4. Saad Muntazim (5 out of 5 patents)

5. Karunakar Neelam (3 out of 3 patents)

6. Shiying Tian (3 out of 3 patents)

7. Mohammed Irfan Syed (2 out of 2 patents)

8. Jason LePree (2 out of 2 patents)

9. Hetalben N Prajapati (1 out of 2 patents)

10. Sudhir Gorukanti (1 out of 4 patents)

11. Hetalben Prajapati (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12758547 - Long acting injectable formulations (2026-10-13),

2. 11801233 - Oral eliglustat transmucosal delivery system (2023-10-31),

3. 11596628 - Long acting injectable formulations (2023-03-07),

4. 11413271 - Oral eliglustat transmucosal delivery system (2022-08-16),

5. 10821118 - Oral transmucosal drug delivery system (2020-11-03),

6. 9795616 - Oral transmucosal drug delivery system (2017-10-24),

7. 9352047 - Oral transmucosal drug delivery system (2016-05-31),

8. 9011912 - Extended-release oral dosage forms for poorly soluble amine drugs (2015-04-21),

Company Overview

Abon Pharmaceuticals LLC is a leading pharmaceutical company dedicated to improving the health and well-being of patients through the development of innovative and high-quality generic drugs. With a strong focus on research and development, Abon Pharmaceuticals is committed to providing affordable and accessible healthcare solutions to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#7 in Northvale, NJ

#1,343 in New Jersey

#35,941 in US

Northvale, NJ, United States of America

Abon Pharmaceuticals LLC

Forward Citations = 33

11 inventors:

Yanming Zu (8 out of 8 patents)

Salah Uddin Ahmed (8 out of 25 patents)

Tahseen A Chowdhury (7 out of 16 patents)

4. Saad Muntazim (5 out of 5 patents)

5. Karunakar Neelam (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abon Pharmaceuticals LLC. Retrieved from https://idiyas.com/company/abon-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]